Our group demonstrated that expression of OCTN2 is increased in GBM compared to healthy brain tissue [12] implying a role in GBM progression which could possibly be attributed to the GBM’s dependence on a functioning FAO. The gene discussed is SLC22A5; the disease is glioblastoma.